Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02066532
Title Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Kevin Kalinsky
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mount Sinai Medical Center New York New York 10029 United States Details
Columbia University Medical Center New York New York 10032 United States Details
New York Hospital-Weill Cornell Medical Center New York New York 10065 United States Details
Montefiore Medical Center New York New York 10461 United States Details
*Shaded cells indicate that there was no data available from for the field